# Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation

> **NCT06214403** · PHASE2 · WITHDRAWN · sponsor: **University Health Network, Toronto**

## Conditions studied

- Gram-negative Bacteremia
- Microbial Colonization
- Antibiotic Resistant Infection

## Interventions

- **DRUG:** MET-2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06214403
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2026-07
- **Primary completion:** 2028-01
- **Final completion:** 2028-07
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study intervention not available. Manufacturer no longer producing MET-2.
- **Last updated:** 2026-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06214403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06214403, "Antimicrobial Resistant Organism Decolonization After Microbiome Perturbation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06214403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*